Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-22-010429

Dake Benjamin T sold 23,560 shares at an average $15.91 ($374,803)

  • Dake Benjamin T acquired 23,560 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Dake Benjamin T

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2022-10-06 Exercise or conversion : show line 1 in the form +2,411 $1.74 $4,195 2,411 D
2022-10-06 Exercise or conversion : show line 2 in the form +10,629 $2.14 $22,746 13,040 D
2022-10-06 Sale : show line 3 in the form −11,210 $15.64 $175,345 1,830 D
2022-10-06 Sale : show line 4 in the form −882 $16.54 $14,589 948 D
2022-10-06 Sale : show line 5 in the form −948 $17.31 $16,411 0 D
2022-10-07 Exercise or conversion : show line 6 in the form +10,520 $2.14 $22,513 10,520 D
2022-10-07 Sale : show line 7 in the form −8,763 $15.93 $139,631 1,757 D
2022-10-07 Sale : show line 8 in the form −1,757 $16.41 $28,828 0 D
Open-market sales · 23,560 sh · avg $15.91 · $374,803

Table II: Derivative

5 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-10-06 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −905 $1.74 2030-09-03 905 13,583 D
2022-10-06 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −1,506 $1.74 2030-09-03 1,506 33,150 D
2022-10-06 Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) −6,348 $2.14 2031-04-01 6,348 30,552 D
2022-10-06 Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) −4,281 $2.14 2031-04-01 4,281 324,640 D
2022-10-07 Exercise or conversion : show line 13 in the form Stock Option (Right to Buy) −10,520 $2.14 2031-04-01 10,520 314,120 D
Loading xslF345X03/form4-10112022_051001.xml…